Published on August 26 in the journal Nature, the reported transformation is the first to successfully use alcohols as reagents in the so-called alkylation reaction. The unique reaction was actually discovered by chance, said David MacMillan, the James S. McDonnell Distinguished University Professor of Chemistry who led the work.

The research team was exploring alcohol additions when a test reaction revealed a surprising product that lacked the alcohol group. After further investigation, the team realized that the reaction underwent a well-known process in biochemistry, called spin center shift, which is involved in fundamental pathways such as DNA biosynthesis, but has rarely been seen in organic synthesis.

The researchers were able to mimic this natural phenomenon by using two types of catalysis in combination. The first catalyst, known as an iridium photocatalyst, initiates the reaction by taking a single electron from the second catalyst, a compound called a thiol, to form a key intermediate. That intermediate--a thiol radical--is uniquely capable of pulling a hydrogen atom off of the starting alcohol, cleaving a typically strong C-H bond. Breaking this bond reveals an alcohol species that reacts with the heteroarene and then follows the spin center shift pathway found in nature to form the final product.

Using their method, the researchers were able to synthesize a wide range of products, highlighting the incorporation of methyl groups, which is the third most common substituent in pharmaceuticals. MacMillan and coworkers also demonstrated the efficient alkylation of two pharmaceutical compounds, showing its utility for late-stage alkylation.

Taking a cue from nature, the researchers have developed a highly effective and general alkylation method that will be immediately useful in medicinal chemistry settings.

Story Source:

The above post is reprinted from materials provided by Princeton University. Note: Materials may be edited for content and length.